Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 1, 2012, Pages 556-562

  Langan, Sinéad M ^a,b   Seminara, Nicole M ^b   Shin, Daniel B ^b   Troxel, Andrea B ^b   Kimmel, Stephen E ^b   Mehta, Nehal N ^b   Margolis, David J ^b   Gelfand, Joel M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY SURFACE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCREENING TEST; UNITED KINGDOM;

EID: 84857061326     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.365     Document Type: Article

References (31)

1. Abuabara K, Azfar RS, Shin DB et al. (2010) Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K. Br J Dermatol 163:586-92
2. Al-Mutairi N, Al-Farag S, Al-Mutairi A et al. (2010) Comorbidities associated with psoriasis: An experience from the Middle East. J Dermatol 37:146-55
3. Augustin M, Reich K, Glaeske G et al. (2010) Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Dermatol Venereol 90:147-51
4. Azfar R, Gelfand J (2008) Psoriasis and metabolic disease: Epidemiology and pathophysiology. Curr Opin Rheumatol 20:416-22
5. Basarab T, Munn SE, Jones RR (1996) Diagnostic accuracy and appropriateness of general practitioner referals to a dermatology out-patient clinic. Br J Dermatol 135:70-3 (Pubitemid 26225118)
6. Davidovici BB, Sattar N, Prinz JC et al. (2010) Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130: 1785-96
7. Dommasch E, Shin D, Troxel A et al. (2010) Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis. Br J Dermatol 162:835-42
8. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-28 (Pubitemid 40523737)
9. Expert Panel on Detection Ea, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection
10. Feldman SR (2004) A quantitative definition of severe psoriasis for use in clinical trials. J Dermatolog Treat 15:27-9 (Pubitemid 38252092)
11. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-9 (Pubitemid 34251969)
12. Gelfand J, Dommasch E, Shin D et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129:2411-8
13. Gelfand J, Neimann A, Shin D et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-41 (Pubitemid 44547793)
14. Gisondi P, Girolomoni G (2009) Psoriasis and atherothrombotic diseases: Disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 35:313-24
15. Krueger G, Koo J, Lebwohl M et al. (2001) The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137:280-4 (Pubitemid 32240779)
16. Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004. J Am Acad Dermatol 60:218-24
17. Lakka HM, Laaksonen DE, Lakka TA et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-16 (Pubitemid 35403784)
18. Lewis J, Schinnar R, Bilker W et al. (2007) Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16:393-401 (Pubitemid 46656860)
19. Love TJ, Qureshi AA, Karlson EW et al. (2011) Prevalence of the metabolic syndrome in psoriasis: Results from the national health and nutrition examination survey, 2003-2006. Arch Dermatol 147:419-24
20. Mebazaa A, El Asmi M, Zidi W et al. (2011) Metabolic syndrome in Tunisian psoriatic patients: Prevalence and determinants. J Eur Acad Dermatol Venereol 25:705-9
21. Mehta N, Azfar R, Shin D et al. (2010a) Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the General Practice Research Database. Eur Heart J 31:1000-6
22. Mehta NN, McGillicuddy FC, Anderson PD et al. (2010b) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172-81
23. Mente A, Yusuf S, Islam S et al. (2010) Metabolic syndrome and risk of acute myocardial infarction: A case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol 55:2390-8
24. Mokdad AH, Ford ES, Bowman BA et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-9 (Pubitemid 36026281)
25. National Psoriasis Foundation. /http://www.psoriasis.org/netcommunity/ learn-statisticsS Accessed 22 November 2010
26. Nijsten T, Looman CW, Stern RS (2007) Clinical severity of psoriasis in last 20 years of PUVA study. Arch Dermatol 143:1113-21 (Pubitemid 47443362)
27. Phillimore P, Beattie A, Townsend P (1994) Widening inequality of health in northern England, 1981-91. BMJ 308:1125-8 (Pubitemid 24130972)
28. Rothman K, Greenland S (2005) Causation and causal inference in epidemiology. Am J Public Health 95(Suppl 1):S144-50 (Pubitemid 41033428)
29. Seminara NM, Abuabara K, Shin DB et al. (2011) Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 164:602-9
30. Shah R, Lu Y, Hinkle CC et al. (2009) Gene profiling of human adipose tissue during evoked inflammation in vivo. Diabetes 58:2211-9
31. Zimmet P, Magliano D, Matsuzawa Y et al. (2005) The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 12:295-300